Navigation Links
3SBio Inc. Announces Extraordinary General Meeting of Shareholders
Date:3/24/2013

merger.

Shareholders of record as of the close of business in the Cayman Islands on April 12, 2013 will be entitled to vote at the EGM.  The record date for ADS holders entitled to instruct JPMorgan Chase Bank, N.A., the ADS depositary, to vote the shares represented by the ADSs is the close of business in New York City on March 25, 2013.  Additional information regarding the EGM and the Merger Agreement can be found in the Transaction Statement on Schedule 13E-3, and the proxy statement attached as Exhibit (a)-(1) thereto, filed with the Securities and Exchange Commission (the "SEC"), which can be obtained from the SEC's website (http://www.sec.gov).

INVESTORS AND SHAREHOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THESE MATERIALS AND OTHER MATERIALS FILED WITH OR FURNISHED TO THE SEC, AS THEY CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE PROPOSED MERGER AND RELATED MATTERS.

This announcement is neither a solicitation of proxy, an offer to purchase nor a solicitation of an offer to sell any securities and it is not a substitute for any proxy statement or other filings that have been or will be made with the SEC.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people.  Shares trade in the form of ADSs on the NASDAQ global market under the ticker symbol "SSRX".  Please see www.3SBio.com for more information.

For investor
'/>"/>

SOURCE 3SBio Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
2. 3SBio Inc. To Present at the DB Access Asia Conference 2012
3. 3SBio Obtains SFDA Approval to Join Global Phase III Trial for Voclosporin
4. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
5. 3SBio Inc. Announces Changes to Its Board of Directors
6. Apexigen Announces the Filing of an IND by its Partner, 3SBio
7. 3SBio Inc. to Hold 2012 Annual General Meeting on October 10, 2012
8. 3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS
9. 3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal
10. 3SBio Inc. Announces Unaudited Third Quarter 2012 Results
11. 3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
(Date:3/26/2015)...  The Burzynski Research Institute, Inc. (BRI) announced today ... the Department of Surgery at Kurume University Medical ... been published. The study, a randomized non-blinded phase ... post-operative adjuvant therapy with and without Antineoplastons A10/AS2-1 ... A total of 65 patients, with ...
(Date:3/26/2015)... Columbia, March 26, 2015  OncoGenex Pharmaceuticals, Inc. ... of clinical developments and announced fourth quarter and ... Clinical Developments and Anticipated Near-term MilestonesCustirsen ... agreed to negotiate the termination of their collaboration ... the final termination agreement are ongoing. , ...
Breaking Medicine Technology:Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8
... June 29 Perrigo (Nasdaq: PRGO ; TASE) ... brand rights to sell and distribute OTC versions of Fexofenadine ... 60 mg and Pseudoephedrine 120 mg tabs, the generic versions ... Ltd. (Nasdaq: TEVA ) currently has Rx approval for ...
... FREMONT, Calif. , June 29 Vermillion, ... announced that the United States Patent and Trademark Office ... patent entitled "Biomarkers for Alzheimer,s disease" to the Company. ... the diagnosis and management of Alzheimer,s disease and to ...
Cached Medicine Technology:Perrigo Acquires Exclusive Sales and Distribution Rights to OTC Store Brand Versions of Allegra® and Allegra D-12 From Teva 2Perrigo Acquires Exclusive Sales and Distribution Rights to OTC Store Brand Versions of Allegra® and Allegra D-12 From Teva 3Vermillion Announces Issuance of Patent for Alzheimer's Disease Diagnosis 2Vermillion Announces Issuance of Patent for Alzheimer's Disease Diagnosis 3
(Date:3/28/2015)... New York, New York (PRWEB) March 28, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. ... multidistrict litigation underway in U.S. District Court, Southern ... Jeffrey S. Grand, is serving on the Plaintiffs’ ... March 24th, the Court has granted certain defendants ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 India ... coverage is made available to all visitors who purchase ... immediately. All members are encouraged to purchase the insurance ... avoid lack of proper coverage for pre-existing medical conditions. ... one or two medical conditions with serious consequences to ...
(Date:3/28/2015)... 28, 2015 Pitching speed, player’s height, and ... shoulder and elbow injuries, according to new research released today ... ) Specialty Day. , “Our findings indicate that a 10 ... in likelihood of a history of injury, a 10 mile ... increase likelihood of a history of injury, and playing for ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... stiffness may not be necessary, according to research presented ... ( AOSSM ) Specialty Day. , “Our study compared ... with 25 who underwent an additional glenohumeral joint capsule ... surgery,” commented George Murrell MD, PhD, lead author from ...
(Date:3/28/2015)... Andrew Hawley of Vintage Rock Posters Inc., ... posters. The Who and the Doors played together at the ... According to Hawley, “The Who toured the United States heavily ... campuses. Perhaps the most famous Who poster was a poster ... Doors on August 2, 1968 at the Singer Bowl in ...
Breaking Medicine News(10 mins):Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2
... first time organized a rally from medical college campus to ... The main aim of the protest is to condemn the ... Students and interns of two medical colleges Patna Medical College ... participated in the protest rally. ,They have threatened ...
... outbreak of meningitis in Nigeria's northwestern state of Sokoto has ... Agency of Nigeria.// ,The cases of Cerebra Spinal ... figures reveal that at least 14 people have been infected ... in the area, but as of now there are no ...
... Minister of state for Industry Ashwini Kumar speaking at a ... the corporate sector in India to draw up a framework ... It is only then can the physically challenged be ... , The government's commitment towards the community is unflinching ...
... its severe dearth of general practitioners, further substantiated by recent ... of a severe GP crisis. ,The research published in ... of Doctors, gravitating to specialist sectors, which if analyzed over ... and totally understaffed. ,Dr Catherine Joyce from Monash ...
... A nation wide study conducted on more than 57,000 children ... like being poor or having a single mother who is ... sick, immaterial of race or health insurance coverage. ... physically or mentally impoverishing conditions is bad for children, but ...
... an impetus to the weight loss industry a panel comprising ... sales// in the European Union. This news was brought to ... the pill Acomplia (rimonabant) is to block a pleasure centre ... because they feel less pleasure associated with eating. ...
Cached Medicine News:Health News:Minister Of State For Industry Urges Corporate Sectors To Help India's Disabled Population 2Health News:A New Study Shows Social Well Being Plays An Important Part In Childs Health 2Health News:A New Study Shows Social Well Being Plays An Important Part In Childs Health 3
... The Foundation PS knee offers a femoral option ... cam action that engages at 60 degrees of ... motion and allow for 130 degrees of flexion. ... design with prominent lateral flare. The constrained tibial ...
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Profix total knee system is intended for cemented use only....
The LCS complete knee offers grit-blast textured components for cemented implantation and POROCOAT Porous Coated patellar, femoral and tibial components for cementless fixation....
Medicine Products: